|
1
|
Zhang Q, Xiang W, Yi DY, Xue BZ, Wen WW,
Abdelmaksoud A, Xiong NX, Jiang XB, Zhao HY and Fu P: Current
status and potential challenges of mesenchymal stem cell-based
therapy for malignant gliomas. Stem Cell Res Ther.
9(228)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Alphandery E: Glioblastoma treatments: An
account of recent industrial developments. Front Pharmacol.
9(879)2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Towner RA and Smith N: In vivo and in situ
detection of macromolecular free radicals using immuno-spin
trapping and molecular magnetic resonance imaging. Antioxid Redox
Signal. 28:1404–1415. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Feng E, Liang T, Wang X, Du J, Tang K,
Wang X, Wang F and You G: Correlation of alteration of HLA-F
expression and clinical characterization in 593 brain glioma
samples. J Neuroinflammation. 16(33)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tompa M, Kalovits F, Nagy A and Kalman B:
Contribution of the Wnt pathway to defining biology of
glioblastoma. Neuromolecular Med. 20:437–451. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yamini B: NF-κB, mesenchymal
differentiation and glioblastoma. Cells. 7(125)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Brennan CW, Verhaak RG, McKenna A, Campos
B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ,
Berman SH, et al: The somatic genomic landscape of glioblastoma.
Cell. 155:462–477. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cancer Genome Atlas Research Network.
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sato M, Kanemoto H, Kagawa Y, Kobayashi T,
Goto-Koshino Y, Mochizuki H, Takahashi M, Fujino Y, Ohno K and
Tsujimoto H: Evaluation of the prognostic significance of BCL6 gene
expression in canine high-grade B-cell lymphoma. Vet J.
191:108–114. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ang L, Zheng L, Wang J, Huang J, Hu HG,
Zou Q, Zhao Y, Liu QM, Zhao M and Wu ZS: Expression of and
correlation between BCL6 and ZEB family members in patients with
breast cancer. Exp Ther Med. 14:3985–3992. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhu L, Feng H, Jin S, Tan M, Gao S, Zhuang
H, Hu Z, Wang H, Song Z and Lin B: High expressions of BCL6 and
Lewis y antigen are correlated with high tumor burden and poor
prognosis in epithelial ovarian cancer. Tumour Biol.
39(1010428317711655)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Xu L, Chen Y, Dutra-Clarke M, Mayakonda A,
Hazawa M, Savinoff SE, Doan N, Said JW, Yong WH, Watkins A, et al:
BCL6 promotes glioma and serves as a therapeutic target. Proc Natl
Acad Sci USA. 114:3981–3986. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wei Z, Gao W, Wu Y, Ni B and Tian Y:
Mutual interaction between BCL6 and miRNAs contributing to the
pathogenesis of various cancers. Clin Transl Oncol. 17:841–846.
2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhu Z, Wang S, Zhu J, Yang Q, Dong H and
Huang J: MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit
tumor growth of human triple negative breast cancer. Biol Chem.
397:1087–1095. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sun C, Li S, Yang C, Xi Y, Wang L, Zhang F
and Li D: MicroRNA-187-3p mitigates non-small cell lung cancer
(NSCLC) development through down-regulation of BCL6. Biochem
Biophys Res Commun. 471:82–88. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li YY, Shao JP, Zhang SP, Xing GQ and Liu
HJ: miR-519d-3p inhibits cell proliferation and invasion of gastric
cancer by downregulating B-cell lymphoma 6. Cytogenet Genome Res.
154:12–19. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Dragomir M, Mafra ACP, Dias SMG, Vasilescu
C and Calin GA: Using microRNA networks to understand cancer. Int J
Mol Sci. 19(1871)2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang
G, Song J, Li Z, Zhang Z and Yuan W: Effect of exosomal miRNA on
cancer biology and clinical applications. Mol Cancer.
17(147)2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhou Q, Liu J, Quan J, Liu W, Tan H and Li
W: MicroRNAs as potential biomarkers for the diagnosis of glioma: A
systematic review and meta-analysis. Cancer Sci. 109:2651–2659.
2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang S, Yin Y and Liu S: Roles of
microRNAs during glioma tumorigenesis and progression. Histol
Histopathol. 34:213–222. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Huang SW, Ali ND, Zhong L and Shi J:
MicroRNAs as biomarkers for human glioblastoma: Progress and
potential. Acta Pharmacol Sin. 39:1405–1413. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Koshkin FA, Chistyakov DA, Nikitin AG,
Konovalov AN, Potapov AA, Usachyov DY, Pitskhelauri DI, Kobyakov
GL, Shishkina LV and Chekhonin VP: Profile of microRNA expression
in brain tumors of different malignancy. Bull Exp Biol Med.
157:794–797. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yang J, Wang S, Wang F, Mu X, Qu Y, Zhao Z
and Yu X: Downregulation of miR-10b promotes osteoblast
differentiation through targeting Bcl6. Int J Mol Med.
39:1605–1612. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Basso K, Schneider C, Shen Q, Holmes AB,
Setty M, Leslie C and Dalla-Favera R: BCL6 positively regulates AID
and germinal center gene expression via repression of miR-155. J
Exp Med. 209:2455–2465. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yang C, Lv K, Chen B, Yang Y, Ai X, Yu H,
Yang Y, Yi B and Lu K: miR144-3p inhibits PMVECs excessive
proliferation in angiogenesis of hepatopulmonary syndrome via Tie2.
Exp Cell Res. 365:24–32. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang C, He H, Wang L, Jiang Y and Xu Y:
Reduced miR-144-3p expression in serum and bone mediates
osteoporosis pathogenesis by targeting RANK. Biochem Cell Biol.
96:627–635. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li Y, Zhao Y, Cheng M, Qiao Y, Wang Y,
Xiong W and Yue W: Suppression of microRNA-144-3p attenuates
oxygen-glucose deprivation/reoxygenation-induced neuronal injury by
promoting Brg1/Nrf2/ARE signaling. J Biochem Mol Toxicol.
32(e22044)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhang SY, Lu ZM, Lin YF, Chen LS, Luo XN,
Song XH, Chen SH and Wu YL: miR-144-3p, a tumor suppressive
microRNA targeting ETS-1 in laryngeal squamous cell carcinoma.
Oncotarget. 7:11637–11650. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Huo F, Zhang C, He H and Wang Y:
MicroRNA-144-3p inhibits proliferation and induces apoptosis of
human salivary adenoid carcinoma cells via targeting of mTOR.
Biotechnol Lett. 38:409–416. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu C, Yang Z, Deng Z, Zhou Y, Gong Q,
Zhao R and Chen T: Downregulated miR-144-3p contributes to
progression of lung adenocarcinoma through elevating the expression
of EZH2. Cancer Med. 7:5554–5566. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zheng H, Guo Z, Zheng X, Cheng W and Huang
X: MicroRNA-144-3p inhibits cell proliferation and induces cell
apoptosis in prostate cancer by targeting CEP55. Am J Transl Res.
10:2457–2468. 2018.PubMed/NCBI
|
|
33
|
Wu M, Huang C, Huang X, Liang R, Feng Y
and Luo X: MicroRNA-144-3p suppresses tumor growth and angiogenesis
by targeting SGK3 in hepatocellular carcinoma. Oncol Rep.
38:2173–2181. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liu S, Luan J and Ding Y: miR-144-3p
Targets FosB Proto-oncogene, AP-1 transcription factor subunit
(FOSB) to suppress proliferation, migration, and invasion of PANC-1
pancreatic cancer cells. Oncol Res. 26:683–690. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Li X, Li Y, Jiang C, Chen L and Gan N:
MicroRNA-144-3p inhibits tumorigenesis of oral squamous cell
carcinoma by downregulating ERO1L. J Cancer. 11:759–768.
2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Cao XY, Sun ZY, Zhang LJ, Chen MK and Yuan
B: MicroRNA-144-3p suppresses human neuroblastoma cell
proliferation by targeting HOXA7. Eur Rev Med Pharmacol Sci.
23:716–723. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Jiang W, Xu Z, Yu L, Che J, Zhang J and
Yang J: MicroRNA-144-3p suppressed TGF-β1-induced lung cancer cell
invasion and adhesion by regulating the Src-Akt-Erk pathway. Cell
Biol Int 2019 (Epub ahead of print).
|
|
38
|
Wu J, Zhao Y, Li F and Qiao B: miR-144-3p:
A novel tumor suppressor targeting MAPK6 in cervical cancer. J
Physiol Biochem. 75:143–152. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Liu C, Su C, Chen Y and Li G: miR-144-3p
promotes the tumor growth and metastasis of papillary thyroid
carcinoma by targeting paired box gene 8. Cancer Cell Int.
18(54)2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Lou N, Ruan AM, Qiu B, Bao L, Xu YC, Zhao
Y, Sun RL, Zhang ST, Xu GH, Ruan HL, et al: miR-144-3p as a novel
plasma diagnostic biomarker for clear cell renal cell carcinoma.
Urol Oncol. 35:36.e7–36.e14. 2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Xiao W, Lou N, Ruan H, Bao L, Xiong Z,
Yuan C, Tong J, Xu G, Zhou Y, Qu Y, et al: Mir-144-3p promotes cell
proliferation, metastasis, sunitinib resistance in clear cell renal
cell carcinoma by downregulating ARID1A. Cell Physiol Biochem.
43:2420–2433. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Sun X, Liu D, Xue Y and Hu X: Enforced
miR-144-3p expression as a non-invasive biomarker for the acute
myeloid leukemia patients mainly by targeting NRF2. Clin Lab.
63:679–687. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Song L, Chen L, Luan Q and Kong Q:
miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with
PTEN. J Cell Physiol. 234:17912–17924. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Song J, Ma Q, Hu M, Qian D, Wang B and He
N: The Inhibition of miR-144-3p on cell proliferation and
metastasis by targeting TOP2A in HCMV-positive glioblastoma cells.
Molecules. 23(3259)2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Lan F, Yu H, Hu M, Xia T and Yue X:
miR-144-3p exerts anti-tumor effects in glioblastoma by targeting
c-Met. J Neurochem. 135:274–286. 2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Cheng ZX, Song YX, Wang ZY, Wang Y and
Dong Y: miR-144-3p serves as a tumor suppressor by targeting FZD7
and predicts the prognosis of human glioblastoma. Eur Rev Med
Pharmacol Sci. 21:4079–4086. 2017.PubMed/NCBI
|
